Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Anastomotic Leak × Sodium Chloride × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 8 Lung Neoplasms 5 Colorectal Neoplasms 3 Prostatic Neoplasms 2 Neoplasm Metastasis 2 Melanoma 2 Hot Flashes 2 Glioblastoma 2 Carcinoma, Non-Small-Cell Lung 2 Brain Neoplasms 2 Water-Electrolyte Imbalance 1 Surgical Wound 1 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Rectal Neoplasms 1 Pathologic Complete Response 1 Neoplasm, Residual 1 Lymphopenia 1 Lymphoma, Non-Hodgkin 1 Lymphedema 1 Lower Urinary Tract Symptoms 1 Locally Advanced Head and Neck Squamous Cell Carcinoma 1 Leukemia, Myeloid, Acute 1 Leukemia, Hairy Cell 1 Hematologic Neoplasms 1 Heart Failure 1 Glioma 1 Gastrointestinal Neoplasms 1 Fatigue 1 Esophageal Neoplasms 1

Interventions

Water 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Serum Albumin, Human 1 Saline Solution 1 Neomycin 1 Metronidazole 1 Esophagectomy 1 Ciprofloxacin 1 Bioseal 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02682485 2023-04-26

SES-DTA

University of Chicago

Phase 2 Withdrawn

Gastrointestinal

Rectal Neoplasms, Anastomotic Leak

Data powered by HemOnc (CC BY 4.0) Colophon ⚡